Anonymised Clinical Data Key to Understanding Traumatic Brain Injuries
News Dec 11, 2014
Funding for a two-year collaborative project involving health informatics company Aridhia, NHS Greater Glasgow and Clyde, Philips Medical Systems UK and the University of Glasgow was announced today. The funding comes from Innovate UK (formerly TSB) for Digital Health in a Connected Hospital.
The project brings recent advances in big data modelling directly into clinical practice and could lead to improved detection and prediction in the early management of traumatic brain injuries (TBI).
By exploiting big data in a real healthcare setting, it is hoped that clinicians will be able to make treatment decisions earlier, leading, through reduced length of hospital stay and in-hospital mortality, to more cost-effective healthcare delivery.
Aridhia will deploy its data science platform and data safe haven, AnalytiXagility, to securely store and analyse high frequency, anonymised data collected from patients through bedside monitoring systems in the neurointensive care unit at the Southern General Hospital.
The platform will implement an ‘app’ which clinicians will use at the bedside to select clinical analysis algorithms to inform the best course of care for the patient
David Sibbald, CEO at Aridhia, explains: “With few proven effective medical therapies for brain injury, traumatic brain injury is devastating, not only to the victim but also to their carers and to the society that supports their long term recovery, often lasting many years.”
The extension of Aridhia’s platform into a clinical setting will be made possible through a collaborative effort from the team at Aridhia and the expertise provided by the two non-industry partners – NHS Greater Glasgow and Clyde and the University of Glasgow – who will ensure the technology is meeting clinical needs.
NHS Greater Glasgow and Clyde’s Department of Clinical Physics and Bioengineering will provide expertise in managing and analysing the data collected from patient monitoring equipment in the unit. This team from within the Diagnostics Directorate at NHS Greater Glasgow and Clyde, led by Dr Laura Moss, will also assist with the clinical studies conducted as part of the system evaluation.
Clinicians from the University of Glasgow, led by Professor John Kinsella, will provide expertise in anaesthesia, pain and critical care and the design of the clinical trial as well as contributing to the evaluation of the clinical control application.
Aridhia enables translational healthcare by analysing big data and making this available to clinicians in a practical format in a real healthcare setting. The project also demonstrates an important extension to the platform’s ability in receiving and storing high frequency data, analysing this and returning results directly to the original bedside device.
Through the project, Aridhia aims to develop a framework that will enable clinically important physiological models and analysis to be implemented more quickly into clinical practice.
Modern traumatic brain injury (TBI) units have sophisticated bedside monitoring equipment, which means large volumes of high-frequency patient data is available. Currently, summaries of patient data such as blood pressure and intracranial pressure are displayed on monitoring devices to aid clinical decision-making, but, with the analysis of the raw high-frequency data yielding additional, previously unseen clinical information, this has the potential to revolutionise the treatment of TBI patients.
The project collaboration was successful in winning the R&D funding from Innovate UK earlier this year.
LogicTRN Model Illuminates Regulatory Gene FrameworkNews
A newly devised algorithm called LogicTRN has the potential to unravel the complexities of genetic regulation.READ MORE
SLIMS Users Can Now Connect to the iSpecimen MarketplaceNews
Genohm and iSpecimen have jointly announced that Genohm has established a partnership with iSpecimen to enable users of the SLIMS laboratory information management system to seamlessly connect to the iSpecimen Marketplace.READ MORE
Ovation and Coriell Life Sciences Partner to Streamline Genetic Reporting WorkflowsNews
Ovation.io, Inc. (Ovation), makers of the fastest-growing clinical laboratory information and commercialization platform, and Coriell Life Sciences, Inc., an innovative provider of clinical genetic reporting solutions, announced a partnership and platform integration designed to create a seamless ecosystem for sample and workflow management, genetic data interpretation, and external client communication.READ MORE